Zenas BioPharma, Inc.

ZBIO

ZBIOZenas BioPharma, Inc. US flag

NASDAQ Global Select

17.40

USD

+0.27

- -

776.79MMarket Cap

Profitability (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -
Return on Assets (%)	- -	-52.01	-71.66	-100.25
Return on Capital (%)	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -
Gross Margin (%)	- -	100	100	100
EBITDA Margin (%)	- -	-54.07	-3,275.02	-2,113.29
Operating Margin (%)	- -	-54.29	-3,277.76	-2,113.85
Incremental Operating Margin (%)	- -	- -	- -	- -
Pretax Margin (%)	- -	-73.65	-3,131.18	-3,778.16
Profit Margin (%)	- -	-74.25	-3,139.76	-3,777.37
Net Income to Common Margin (%)	- -	-74.25	-3,139.76	-3,777.37
Effective Tax Rate (%)	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -

Credit (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	2	21	1	1
ST Debt	1	1	1	1
LT Debt	1	21	- -	- -
Total Debt/EBITDA	-0.02	-0.78	-0.01	-0.01
Net Debt/EBITDA	0.89	1.35	1.95	0.52
Total Debt/EBIT	-0.02	-0.78	-0.01	-0.01
Net Debt/EBIT	0.89	1.35	1.95	0.52
EBITDA to Interest Expense	- -	- -	- -	-28.84
EBITDA-CapEx/Interest Expense	- -	- -	- -	-33.62
EBIT to Interest Expense	- -	- -	- -	-28.85
Interest Expense	- -	- -	- -	7
Common Equity/Total Assets	-259.16	-337.93	-104.71	-199.44
Long-Term Debt/Equity (%)	- -	- -	0.07	0.09
Long-Term Debt/Capital (%)	-0.42	-9.82	-0.06	-0.03
Long-Term Debt/Total Assets (%)	1.09	30.15	0.06	0.05
Total Debt/Equity (%)	-0.79	-9.35	0.32	0.55
Total Debt/Capital (%)	-0.8	-10.09	-0.26	-0.17
Total Debt/Total Assets (%)	2.05	30.97	0.27	0.35
Net Debt to Equity	34.95	16.2	-102.33	-45.69
Net Debt/Capital (%)	25.95	13.74	45.28	12.65
EBITDA	-75	-27	-164	-211
EBITDA-CapEx	-77	-27	-164	-246
Operating Income (Loss)	-75	-27	-164	-211

Liquidity (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	2.59	2.44	6.12	5.48
Current Ratio	2.64	2.57	6.21	5.61
Quick Ratio	2.59	2.44	6.12	5.48
CFO/Avg Current Liab	- -	-1.24	-2.97	-2.87
Common Equity/Total Assets	-259.16	-337.93	-104.71	-199.44
Long-Term Debt/Equity (%)	- -	- -	0.07	0.09
Long-Term Debt/Capital (%)	-0.42	-9.82	-0.06	-0.03
Long-Term Debt/Total Assets (%)	1.09	30.15	0.06	0.05
Total Debt/Equity (%)	-0.79	-9.35	0.32	0.55
Total Debt/Capital (%)	-0.8	-10.09	-0.26	-0.17
Total Debt/Total Assets (%)	2.05	30.97	0.27	0.35
CFO/Total Liabilities	-24.6	-10.39	-208.09	-121.79
CFO/CapEx	-29.87	-1,795.82	-913.54	-4.92
Altman's Z-Score	-6.27	-4.67	-0.82	-3.68

Working Capital (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -
Inventories	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	108	- -
- Cash & Cash Equivalents	67	57	320	111
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -
+ Total Debt	2	21	1	1
Enterprise Value	-66	-36	-242	-342
Total Capital	-192	-209	-386	-764
Total Debt/Capital (%)	-0.8	-10.09	-0.26	-0.17
Total Debt / EV	-0.02	-0.59	- -	- -
EV/Sales	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -
Diluted Market Cap	- -	- -	108	- -
Diluted Enterprise Value	-66	-36	-211	-109
EV per Share	- -	- -	- -	- -
TTM Sales	- -	50	5	10
TTM EBITDA	-75	-27	-164	-211
TTM Operating Income	-75	-27	-164	-211
TTM Cash Flow to Firm	-66	-31	-120	-165
TTM Free Cash Flow to Firm	-63	-31	-120	-130

Multiples (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-0.9	- -
EV/EBIT	- -	- -	- -	- -
Enterprise Value	-66	-36	-242	-342
Low Price	- -	- -	7.79	5.83
EV/Sales	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-1.34	- -
Price/Earnings High	- -	- -	-2.21	- -
Price/Earnings Low	- -	- -	-0.65	- -
Price/Book Value	- -	- -	-0.28	- -
Price/Book Value Average	- -	- -	-0.54	- -
Price/Book Value High	- -	- -	-0.89	- -
Price/Book Value Low	- -	- -	-0.27	- -
Price/Tangible Book Value	- -	- -	0.35	- -
Price/Tangible Book Value Average	- -	- -	0.67	- -
Price/Tangible Book Value High	- -	- -	1.11	- -
Price/Tangible Book Value Low	- -	- -	0.33	- -
Price/Sales	- -	- -	21.62	- -
Price/Sales Average	- -	- -	42.17	- -
Price/Sales High	- -	- -	69.29	- -
Price/Sales Low	- -	- -	20.56	- -
Price/Cash Flow	- -	- -	-0.9	- -
Price/Cash Flow Average	- -	- -	-1.76	- -
Price/Cash Flow High	- -	- -	-2.9	- -
Price/Cash Flow Low	- -	- -	-0.86	- -
Price/Free Cash Flow Average	- -	- -	-1.76	- -
Price/Free Cash Flow High	- -	- -	-2.9	- -
Price/Free Cash Flow Low	- -	- -	-0.86	- -
EV/Sales Average	- -	- -	- -	- -
EV/Sales High	- -	- -	5.55	- -
EV/Sales Low	- -	- -	- -	- -
EV/EBITDA Average	0.87	1.32	0.66	0.52
EV/EBITDA High	0.87	1.32	-0.17	0.52
EV/EBITDA Low	0.87	1.32	1.32	0.52
EV/EBIT Average	0.87	1.32	0.66	0.52
EV/EBIT High	0.87	1.32	-0.17	0.52
EV/EBIT Low	0.87	1.32	1.32	0.52
Last Price	- -	- -	8.19	36.31
High Price	- -	- -	26.25	44.6
Enterprise Value Average	-66	-36	-108	-109
Enterprise Value High	-66	-36	28	-109
Enterprise Value Low	-66	-36	-216	-109

Profitability (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -
Return on Assets (%)	- -	-52.01	-71.66	-100.25
Return on Capital (%)	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -
Gross Margin (%)	- -	100	100	100
EBITDA Margin (%)	- -	-54.07	-3,275.02	-2,113.29
Operating Margin (%)	- -	-54.29	-3,277.76	-2,113.85
Incremental Operating Margin (%)	- -	- -	- -	- -
Pretax Margin (%)	- -	-73.65	-3,131.18	-3,778.16
Profit Margin (%)	- -	-74.25	-3,139.76	-3,777.37
Net Income to Common Margin (%)	- -	-74.25	-3,139.76	-3,777.37
Effective Tax Rate (%)	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -

Credit (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	2	21	1	1
ST Debt	1	1	1	1
LT Debt	1	21	- -	- -
Total Debt/EBITDA	-0.02	-0.78	-0.01	-0.01
Net Debt/EBITDA	0.89	1.35	1.95	0.52
Total Debt/EBIT	-0.02	-0.78	-0.01	-0.01
Net Debt/EBIT	0.89	1.35	1.95	0.52
EBITDA to Interest Expense	- -	- -	- -	-28.84
EBITDA-CapEx/Interest Expense	- -	- -	- -	-33.62
EBIT to Interest Expense	- -	- -	- -	-28.85
Interest Expense	- -	- -	- -	7
Common Equity/Total Assets	-259.16	-337.93	-104.71	-199.44
Long-Term Debt/Equity (%)	- -	- -	0.07	0.09
Long-Term Debt/Capital (%)	-0.42	-9.82	-0.06	-0.03
Long-Term Debt/Total Assets (%)	1.09	30.15	0.06	0.05
Total Debt/Equity (%)	-0.79	-9.35	0.32	0.55
Total Debt/Capital (%)	-0.8	-10.09	-0.26	-0.17
Total Debt/Total Assets (%)	2.05	30.97	0.27	0.35
Net Debt to Equity	34.95	16.2	-102.33	-45.69
Net Debt/Capital (%)	25.95	13.74	45.28	12.65
EBITDA	-75	-27	-164	-211
EBITDA-CapEx	-77	-27	-164	-246
Operating Income (Loss)	-75	-27	-164	-211

Liquidity (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	2.59	2.44	6.12	5.48
Current Ratio	2.64	2.57	6.21	5.61
Quick Ratio	2.59	2.44	6.12	5.48
CFO/Avg Current Liab	- -	-1.24	-2.97	-2.87
Common Equity/Total Assets	-259.16	-337.93	-104.71	-199.44
Long-Term Debt/Equity (%)	- -	- -	0.07	0.09
Long-Term Debt/Capital (%)	-0.42	-9.82	-0.06	-0.03
Long-Term Debt/Total Assets (%)	1.09	30.15	0.06	0.05
Total Debt/Equity (%)	-0.79	-9.35	0.32	0.55
Total Debt/Capital (%)	-0.8	-10.09	-0.26	-0.17
Total Debt/Total Assets (%)	2.05	30.97	0.27	0.35
CFO/Total Liabilities	-24.6	-10.39	-208.09	-121.79
CFO/CapEx	-29.87	-1,795.82	-913.54	-4.92
Altman's Z-Score	-6.27	-4.67	-0.82	-3.68

Working Capital (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -
Inventories	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	108	- -
- Cash & Cash Equivalents	67	57	320	111
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -
+ Total Debt	2	21	1	1
Enterprise Value	-66	-36	-242	-342
Total Capital	-192	-209	-386	-764
Total Debt/Capital (%)	-0.8	-10.09	-0.26	-0.17
Total Debt / EV	-0.02	-0.59	- -	- -
EV/Sales	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -
Diluted Market Cap	- -	- -	108	- -
Diluted Enterprise Value	-66	-36	-211	-109
EV per Share	- -	- -	- -	- -
TTM Sales	- -	50	5	10
TTM EBITDA	-75	-27	-164	-211
TTM Operating Income	-75	-27	-164	-211
TTM Cash Flow to Firm	-66	-31	-120	-165
TTM Free Cash Flow to Firm	-63	-31	-120	-130

Multiples (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-0.9	- -
EV/EBIT	- -	- -	- -	- -
Enterprise Value	-66	-36	-242	-342
Low Price	- -	- -	7.79	5.83
EV/Sales	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-1.34	- -
Price/Earnings High	- -	- -	-2.21	- -
Price/Earnings Low	- -	- -	-0.65	- -
Price/Book Value	- -	- -	-0.28	- -
Price/Book Value Average	- -	- -	-0.54	- -
Price/Book Value High	- -	- -	-0.89	- -
Price/Book Value Low	- -	- -	-0.27	- -
Price/Tangible Book Value	- -	- -	0.35	- -
Price/Tangible Book Value Average	- -	- -	0.67	- -
Price/Tangible Book Value High	- -	- -	1.11	- -
Price/Tangible Book Value Low	- -	- -	0.33	- -
Price/Sales	- -	- -	21.62	- -
Price/Sales Average	- -	- -	42.17	- -
Price/Sales High	- -	- -	69.29	- -
Price/Sales Low	- -	- -	20.56	- -
Price/Cash Flow	- -	- -	-0.9	- -
Price/Cash Flow Average	- -	- -	-1.76	- -
Price/Cash Flow High	- -	- -	-2.9	- -
Price/Cash Flow Low	- -	- -	-0.86	- -
Price/Free Cash Flow Average	- -	- -	-1.76	- -
Price/Free Cash Flow High	- -	- -	-2.9	- -
Price/Free Cash Flow Low	- -	- -	-0.86	- -
EV/Sales Average	- -	- -	- -	- -
EV/Sales High	- -	- -	5.55	- -
EV/Sales Low	- -	- -	- -	- -
EV/EBITDA Average	0.87	1.32	0.66	0.52
EV/EBITDA High	0.87	1.32	-0.17	0.52
EV/EBITDA Low	0.87	1.32	1.32	0.52
EV/EBIT Average	0.87	1.32	0.66	0.52
EV/EBIT High	0.87	1.32	-0.17	0.52
EV/EBIT Low	0.87	1.32	1.32	0.52
Last Price	- -	- -	8.19	36.31
High Price	- -	- -	26.25	44.6
Enterprise Value Average	-66	-36	-108	-109
Enterprise Value High	-66	-36	28	-109
Enterprise Value Low	-66	-36	-216	-109

	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	40	40	42	54
Diluted Weighted Avg Shares	13	17	13	- -
Basic Weighted Avg Shares	13	17	13	- -
Revenue per Share	- -	2.87	0.38	- -
EBITDA per Share	-5.83	-1.55	-12.41	- -
Operating Income per Share	-5.84	-1.56	-12.42	- -
Basic EPS, GAAP	-9.26	-2.13	-11.89	- -
Basic EPS from Cont Ops	-9.26	-2.13	-11.89	- -
Diluted EPS, GAAP	-9.26	-2.13	-11.89	- -
Diluted EPS from Cont Ops	-9.26	-2.13	-11.89	- -
Dividend per Share	- -	- -	- -	- -
Cash Flow per Share	-5.1	-1.75	-9.07	- -
Free Cash Flow per Basic Share	-5.27	-1.75	-9.08	- -
Cash & Equivalents per Share	5.22	3.26	26.58	- -
Book Value per Share	-15.01	-13.23	-29.35	- -
Tangible Book Value per Share	-14.93	-12.96	23.67	- -

Zenas BioPharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)